Anemia in heart failure: Association of hepcidin levels to iron deficiency in stable outpatients

Acta Haematologica

Volumn 129, Issue 1, 2013, Pages 55-61

  Weber, Cristiane S ^a   Beck Da Silva, Luis ^a   Goldraich, Livia A ^a   Biolo, Andréia ^a   Clausell, Nadine ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Anemia; Heart failure; Hepcidin; Inflammation; Iron deficiency

Indexed keywords

ERYTHROPOIETIN; HEPCIDIN; IRON; TUMOR NECROSIS FACTOR ALPHA; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HEMOGLOBIN; SPIRONOLACTONE;

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC HEART FAILURE; CLINICAL ARTICLE; INFLAMMATION; IRON DEFICIENCY; IRON METABOLISM; OUTPATIENT;

AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; ANTIMICROBIAL CATIONIC PEPTIDES; CROSS-SECTIONAL STUDIES; ERYTHROPOIETIN; FEMALE; HEART FAILURE; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; ODDS RATIO; OUTPATIENTS; RECEPTORS, TRANSFERRIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84868607860     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000342110     Document Type: Article

References (32)

1. Anand IS: Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008; 52: 501-511
2. Tang YD, Katz SD: Anemia in chronic heart failure: Prevalence, etiology, clinical correlates, and treatment options. Circulation 2006; 113: 2454-2461 (Pubitemid 43948053)
3. Berry C, Hogg K, Norrie J, Stevenson K, Brett M, McMurray J: Heart failure with preserved left ventricular systolic function: A hospital cohort study. Heart 2005; 91: 907-913 (Pubitemid 40874079)
4. Tang WH, Tong W, Jain A, Francis GS, Harris CM, Young JB: Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2008; 51: 569-576
5. Ezekowitz JA, McAlister FA, Armstrong PW: Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003; 107: 223-225 (Pubitemid 36135214)
6. Yasaka Y, Yamabe H, Yokoyama M: Dependence of peak oxygen uptake on oxygen transport capacity in chronic heart failure: Comparison of graded protocol and fixed protocol. Int J Cardiol 1997; 59: 149-156 (Pubitemid 27192058)
7. Adlbrecht C, Kommata S, Hulsmann M, Szekeres T, Bieglmayer C, Strunk G, Karanikas G, Berger R, Mortl D, Kletter K, Maurer G, Lang IM, Pacher R: Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume. Eur Heart J 2008; 29: 2343-2350
8. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI: Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006; 48: 2485- 2489 (Pubitemid 44881220)
9. Beck da Silva L, Rohde LE, Clausell N: Etiology and management of anemia in patients with heart failure: How much iron is missing? Congest Heart Fail 2008; 14: 25-30
10. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, Tramarin R, Tavazzi L: Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 2005; 26: 2232- 2237 (Pubitemid 41541385)
11. Westenbrink BD, Visser FW, Voors AA, Smilde TD, Lipsic E, Navis G, Hillege HL, van Gilst WH, van Veldhuisen DJ: Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J 2007; 28: 166-171
12. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH, Nizet V, Johnson RS: Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 2007; 117: 1926-1932 (Pubitemid 47036326)
13. Ganz T: Hepcidin and its role in regulating systemic iron metabolism. Hematol Am Soc Hematol Educ Program 2006; 2006:29-35, 507
14. Dallman PR: Iron Nutrition in Health and Disease. Eastleigh, John Libbey & Co, 1996
15. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P: Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-2448
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470 (Pubitemid 29135798)
17. Grossman GB, Rohde LE, Clausell N: Evidence for increased peripheral production of tumor necrosis factor-alpha in advanced congestive heart failure. Am J Cardiol 2001; 88: 578-581 (Pubitemid 32778513)
18. Koulaouzidis A, Saeed AA, Abdallah M, Said EM: Transferrin receptor level as surrogate peripheral blood marker of iron deficiency states. Scand J Gastroenterol 2009; 44: 126- 127
19. Rohde LE, Beck da Silva L, Goldraich L, Grazziotin TC, Palombini DV, Polanczyk CA, Clausell N: Reliability and prognostic value of traditional signs and symptoms in outpatients with congestive heart failure. Can J Cardiol 2004; 20: 697-702 (Pubitemid 38968019)
20. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, Mancini DM: Hemodilution is common in patients with advanced heart failure. Circulation 2003; 107: 226-229 (Pubitemid 36135215)
21. Matsumoto M, Tsujino T, Lee-Kawabata M, Naito Y, Akahori H, Sakoda T, Ohyanagi M, Tomosugi N, Masuyama T: Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia. Circ J 2010; 74: 301-306
22. van der Putten K, Jie KE, van den Broek D, Kraaijenhagen RJ, Laarakkers C, Swinkels DW, Braam B, Gaillard CA: Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients. Eur J Heart Fail 2010; 12: 943-950
23. Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T: Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 2009; 296:H585-H593
24. Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P: Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: A randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008; 51: 103-112
25. Maeder MT, Khammy O, dos Remedios C, Kaye DM: Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol 2011; 58:474-480
26. Leszek P, Sochanowicz B, Szperl M, Kolsut P, Brzoska K, Piotrowski W, Rywik TM, Danko B, Polkowska-Motrenko H, Rozanski JM, Kruszewski M: Myocardial iron homeostasis in advanced chronic heart failure patients. Int J Cardiol 2012; 159: 47-52
27. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin- Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P: Iron deficiency: An ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010; 31:1872-1880
28. Okonko DO, Anker SD: Anemia in chronic heart failure: Pathogenetic mechanisms. J Card Fail 2004; 10:S5-S9
29. Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R, Chapman CM: Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006; 48:1225-1227 (Pubitemid 44345150)
30. Toblli JE, Lombrana A, Duarte P, Di Gennaro F: Intravenous iron reduces NT-probrain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007; 50: 1657- 1665 (Pubitemid 47562670)
31. Usmanov RI, Zueva EB, Silverberg DS, Shaked M: Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J Nephrol 2008;21: 236-42
32. Gaber R, Kotb NA, Ghazy M, Nagy HM, Salama M, Elhendy A: Tissue doppler and strain rate imaging detect improvement of myocardial function in iron deficient patients with congestive heart failure after iron replacement therapy. Echocardiography 2011, E-pub ahead of print